A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety
Tekijät: Laitinen K, Isolauri E, Kaipiainen L, Gylling H, Miettinen TA
Kustantaja: CAMBRIDGE UNIV PRESS
Julkaisuvuosi: 2009
Tietokannassa oleva lehden nimi: BRITISH JOURNAL OF NUTRITION
Lehden akronyymi: BRIT J NUTR
Vuosikerta: 101
Numero: 12
Aloitussivu: 1797
Lopetussivu: 1804
Sivujen määrä: 8
ISSN: 0007-1145
DOI: https://doi.org/10.1017/S0007114508133608
Tiivistelmä
Clinical safety of consuming plant stanol ester spreads during pregnancy and lactation, the impact on maternal and infant serum and breast-milk cholesterol and the ratios (mu mol/mmol of cholesterol) of synthesis and absorption markers were evaluated. Pregnant women (n 21) were randomised to control and dietary intervention groups, the intervention including advice to follow a balanced diet and to consume spreads enriched with plant stanol esters. Participants were followed during and after pregnancy and their infants up to 1 year of age. A mean 1-1 (SD 0.4) g consumption of plant stanols during pregnancy and 1.4 (SD 0.9) g 1 month post-partum increased sitostanol and the markers for cholesterol synthesis, lathosterol, lathosterol/campesterol and lathosterol/sitosterol, and reduced a market for cholesterol absorption, campesterol, in maternal serum. In breast milk, desmosterol was lower in the intervention group, while no differences were detected between the groups in infants' serum. Plant stanol ester spread consumption had no impact on the length of gestation, infants' growth or serum beta-carotene concentration at 1 and 6 months of age, but the cholesterol-adjusted serum beta-carotene concentration was lowered at 1 month in the intervention group. Plant stanol ester spread consumption appeared safe in the clinical setting, except for potential lowering of infants' serum beta-carotene concentration, and was reflected in the markers of cholesterol synthesis and absorption in mothers' serum, encouraging further studies in larger settings.
Clinical safety of consuming plant stanol ester spreads during pregnancy and lactation, the impact on maternal and infant serum and breast-milk cholesterol and the ratios (mu mol/mmol of cholesterol) of synthesis and absorption markers were evaluated. Pregnant women (n 21) were randomised to control and dietary intervention groups, the intervention including advice to follow a balanced diet and to consume spreads enriched with plant stanol esters. Participants were followed during and after pregnancy and their infants up to 1 year of age. A mean 1-1 (SD 0.4) g consumption of plant stanols during pregnancy and 1.4 (SD 0.9) g 1 month post-partum increased sitostanol and the markers for cholesterol synthesis, lathosterol, lathosterol/campesterol and lathosterol/sitosterol, and reduced a market for cholesterol absorption, campesterol, in maternal serum. In breast milk, desmosterol was lower in the intervention group, while no differences were detected between the groups in infants' serum. Plant stanol ester spread consumption had no impact on the length of gestation, infants' growth or serum beta-carotene concentration at 1 and 6 months of age, but the cholesterol-adjusted serum beta-carotene concentration was lowered at 1 month in the intervention group. Plant stanol ester spread consumption appeared safe in the clinical setting, except for potential lowering of infants' serum beta-carotene concentration, and was reflected in the markers of cholesterol synthesis and absorption in mothers' serum, encouraging further studies in larger settings.
Turun yliopiston Tutkimustietojärjestelmän portaali